No Data
No Data
Express News | Jasper Therapeutics Inc - Initial Data Expected in Second Half of 2025
Express News | Jasper Therapeutics Announces First Patient Dosed in Phase 1B/2a Etesian Clinical Study of Briquilimab in Asthma
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma
We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
Is Jasper Therapeutics (NASDAQ:JSPR) In A Good Position To Deliver On Growth Plans?
Is Jasper Therapeutics (JSPR) the Best Multibagger Stock to Buy Heading Into 2025?
Unlock the Full List
Kamacho09 OP : Shoulda bought more at 15